In 2025, Brookfield acquired Antylia Scientific in an investment that reflects our established approach of buying essential businesses for value and driving operational value creation.

The company is a leading manufacturer of specialty lab products that are critical to the global life sciences and environmental industries, providing the accuracy and reliability that the world depends on. We are partnering with Antylia to bring together a fragmented network of facilities and position the business as an integrated platform.